| ELANCO ANIMAL HEALTH. |
| USA |
| Gesundheit |
| US28414H1032 / A2N6BH |
| 5EA (Frankfurt) / ELAN (NYSE) |
| FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN |
| - |
| https://www.elanco.com/ |
|
Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to prevent and treat diseases in both companion anim..
>Volltext.. |
| 9993.09 Mio. EUR |
| 13060.6 Mio. EUR |
| 4097.35 Mio. EUR |
| 809.91 Mio. EUR |
| -201.61 Mio. EUR |
| -0.41 EUR |
| 3598.54 Mio. EUR |
| 473.61 Mio. EUR |
| 486.64 Mio. EUR |
| 0.34 |
| -6.38% |
| -160.5% |
| - |
| - |
| - |
| - |
| ELANCO |
| 31.03.26 |
|
||||
|
||||
|